Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,825
Award facts
- Contract value 100% obligated
- $70,825.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $70,825.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on November 12, 2025, with an ultimate completion date of November 21, 2025, represents one of multiple orders placed under DMS Pharmaceutical Group's newly awarded Indefinite Delivery Contract (IDC) within the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract was issued without set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense's pharmaceutical supply chain, with no identified subcontractors on this award.
This delivery order is issued under the broader $30.3 billion PPV-G GEN V acquisition strategy, which establishes multiple regional prime vendor contractors to support recurring medical supply needs for military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured to enable the company to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations globally. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMMT?
SPE2DU26FEMMT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DU26FEMMT worth?
The government has obligated $70,825 on SPE2DU26FEMMT.
Is contract SPE2DU26FEMMT an order under another contract?
Yes. SPE2DU26FEMMT is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMT competed?
The extent of competition for SPE2DU26FEMMT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award